Measuring Quality in Colorectal Cancer Surgery in Low- and Middle-income Countries

Sponsor
Sahlgrenska University Hospital, Sweden (Other)
Overall Status
Completed
CT.gov ID
NCT05182762
Collaborator
(none)
100
1
22
4.5

Study Details

Study Description

Brief Summary

To test the applicability of the Clavien-Dindo Classification (CDC) in an LMIC setting and to compare the prevalence and severity of complications in patients <60 and ≥60 years of age a retrospective medical records review is used.

Detailed Description

Background: Colorectal cancer (CRC) is increasing in Low- and Middle-Income Countries (LMIC) as part of the ongoing epidemiological transition. Surgery is the main treatment and the global health agenda is increasingly putting focus on improving the safety and quality of surgical care in low-resource settings. The current systems for measuring surgical quality are mainly customized for high-income countries.

Aim: To test the applicability of the Clavien-Dindo Classification (CDC) in an LMIC setting. Additionally, to compare the prevalence and severity of complications in patients <60 and ≥60 years of age.

Material and methods: Retrospective medical records review for postoperative complications and severity grading using the CDC.

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Measuring Quality in Colorectal Cancer Surgery in Low- and Middle-income Countries: the Clavien-Dindo Classification in a Sri Lankan Cohort
Actual Study Start Date :
Feb 1, 2020
Actual Primary Completion Date :
Mar 17, 2020
Actual Study Completion Date :
Dec 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Clavien-Dindo Grade [February 2020 to March 2020]

    Postoperative complications graded by the Clavien-Dindo Classification.

Secondary Outcome Measures

  1. Age comparison [February 2020 to March 2020]

    Comparison of prevalence and severity of complications between patients <60 and ≥60 years of age.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who has gone through colorectal cancer resection.

  • Surgery performed at Colombo South Teaching Hospital in Colombo, Sri Lanka.

Exclusion Criteria:
  • Reason for resection other than colorectal cancer.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Gothenburg, Sahlgrenska Academy Gothenburg Sweden

Sponsors and Collaborators

  • Sahlgrenska University Hospital, Sweden

Investigators

  • Study Director: David Ljungman, MD PhD, Dep. of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg..
  • Principal Investigator: Stina Lindholm, MD, Sahlgrenska Academy, University of Gothenburg.
  • Principal Investigator: Sofia Lindskogen, MD, Sahlgrenska Academy, University of Gothenburg.
  • Study Director: Göran Kurlberg, Asoc prof, Dep. of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg.
  • Study Director: Bawantha Gamage, MD, Dep. of Surgery, Colombo South Teaching Hospital, University of Sri Jayewardenepura.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
David Ljungman, Consultant surgeon, Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT05182762
Other Study ID Numbers:
  • MO/PLEC/2020:822
First Posted:
Jan 10, 2022
Last Update Posted:
Jan 10, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by David Ljungman, Consultant surgeon, Sahlgrenska University Hospital, Sweden
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 10, 2022